Anthony Khawaja (Moorfields, UK) talks about the unmet needs in glaucoma including late detection due to insufficient screening methods along with limited understanding of how well a patient will respond to treatment. Research into genetic factors is an exciting area of current and future research.
1. What have been the most significant recent developments in glaucoma research? (0:04)
2. Discuss the current unmet needs and/or the challenges you face when treating glaucoma patients. (0:57)
3. What are the most promising areas of research in your field? (1:58)
4. Do you have a message for young ophthalmologists in Europe? (2:37)
Filmed in partnership with European Society of Ophthalmology (SOE) at the SOE 2019 meeting in Nice, France.
Share this Video
Related Videos In Glaucoma
Thomas V Johnson, AGS 2021: Current Status and Future Challenges of Stem Cell-based Retinal Ganglion Cell Transplantation in Glaucoma Therapy
We were delighted to speak with Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) and find out his thoughts on the current status and future challenges of stem cell-based retinal ganglion cell transplantation in glaucoma therapy, and the challenges and opportunities of the online format of this year’s virtual meeting. […]
Thomas V Johnson, AGS 2021: Cell Intrinsic and Microenvironmental Modulators of Human Stem Cell Derived RGC Survival and Retinal Integration Following Transplantation
It was a pleasure to speak to Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) about his presentation at AGS 2021, investigating cell intrinsic and microenvironmental modulators of retinal ganglion cell survival and retinal integration following transplantation. Questions What were the aims and design of your study investigating cell intrinsic […]
Qi Cui, AGS 2021: Promising Novel Therapies in Glaucoma and Meeting Highlights
It was great to speak with Dr Qi Cui (Scheie Eye Institute, University of Pennsylvania, PA, USA) about her views on the most promising novel therapies targeting risk factors other than intraocular pressure in glaucoma, and her highlights from AGS21. Questions What are the most promising novel therapies targeting risk factors other than intraocular pressure […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!